Synopsys (NASDAQ:SNPS – Get Free Report) had its price target boosted by equities research analysts at Piper Sandler from $430.00 to $450.00 in a report released on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the semiconductor company’s stock. Piper Sandler’s target price points to a potential downside of 14.44% from the company’s previous close.
A number of other analysts have also recently weighed in on SNPS. Citigroup boosted their price objective on shares of Synopsys from $580.00 to $600.00 and gave the stock a “buy” rating in a research note on Wednesday, May 13th. HSBC cut shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price objective for the company. in a research note on Friday, February 20th. The Goldman Sachs Group set a $600.00 price objective on shares of Synopsys and gave the stock a “buy” rating in a research note on Wednesday, February 25th. Needham & Company LLC restated a “buy” rating on shares of Synopsys in a research note on Thursday, February 26th. Finally, Morgan Stanley restated an “equal weight” rating and issued a $480.00 price objective (down from $550.00) on shares of Synopsys in a research note on Wednesday, February 25th. Nine analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Synopsys presently has an average rating of “Hold” and an average price target of $546.13.
Check Out Our Latest Report on Synopsys
Synopsys Price Performance
Synopsys (NASDAQ:SNPS – Get Free Report) last posted its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The firm had revenue of $2.28 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same period in the previous year, the company earned $3.67 earnings per share. The company’s revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, equities analysts predict that Synopsys will post 10.28 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Synopsys
A number of institutional investors and hedge funds have recently bought and sold shares of SNPS. Sankala Group LLC bought a new stake in shares of Synopsys in the 4th quarter worth about $25,000. Thurston Springer Miller Herd & Titak Inc. bought a new stake in shares of Synopsys in the 4th quarter worth about $28,000. Caitong International Asset Management Co. Ltd bought a new stake in shares of Synopsys in the 4th quarter worth about $28,000. IMG Wealth Management Inc. bought a new stake in shares of Synopsys in the 1st quarter worth about $30,000. Finally, Atlas Capital Advisors Inc. bought a new stake in shares of Synopsys in the 4th quarter worth about $32,000. Institutional investors own 85.47% of the company’s stock.
Key Synopsys News
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys beat Q2 estimates with revenue of $2.276 billion and non-GAAP EPS of $3.35, while also raising its full-year revenue and EPS outlook on strong demand for AI-driven chip design software. Reuters article
- Positive Sentiment: The company said backlog remains large and highlighted momentum from AI infrastructure spending and successful progress on Ansys integration, which supports confidence in future growth. Yahoo Finance article
- Positive Sentiment: Synopsys also reached a governance agreement with activist investor Elliott, adding Jesse Cohn to the board, a move that may increase pressure for margin improvement and capital discipline. WSJ article
- Neutral Sentiment: Despite the beat-and-raise report, several market reports noted the stock slipped anyway, suggesting investors may be taking profits or waiting for more clarity on valuation and merger integration before rewarding the results. Barron’s article
- Negative Sentiment: The market’s muted reaction implies concern that much of the AI growth and guidance strength may already be priced into SNPS after a sharp run-up, limiting upside despite the solid quarter. Yahoo Finance article
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Read More
- Five stocks we like better than Synopsys
- Bath & Body Works Stock Surged Despite Falling Sales—Here’s Why
- Dick’s Sporting Goods Isn’t Done Winning Yet
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
